J.J. McCarthy's availability for Week 13 is up in the air. The Minnesota Vikings quarterback is in the concussion protocol following Sunday's loss to the Green Bay Packers, head coach Kevin O'Connell ...

J.J. McCarthy entered a league of his own in Vikings vs. Lions. J.J. McCarthy returned, leading the Vikings to a 27-24 win over the Lions. McCarthy makes NFL history in third game of NFL career.

The Minnesota Vikings are at a crossroads. The organization enters Week 9 a game below .500 with a 3-4 record, which is good for last place in the vaunted NFC North. Maybe more dire than their record, ...

London — Thousands of people in the United Kingdom have filed a joint legal claim estimated to be worth more than £1 billion ($1.34 billion) against Johnson & Johnson, accusing the U.S. pharmaceutical ...

For the first time in the U.K., Johnson & Johnson (NYSE:JNJ) is facing lawsuits over claims that the company’s talc-based products caused cancer after thousands of people sued the U.S. drugmaker this ...

More than 3,000 people in Britain have joined a lawsuit accusing the company of knowing that its baby powder contained carcinogenic fibers, including asbestos. By Eshe Nelson Eshe Nelson covers the ...

Johnson & Johnson has moved swiftly to challenge a headline-grabbing $966 million talc verdict against it in Los Angeles County court, saying the verdict is the result of a "jury process gone awry." ...

LONDON (Reuters) -Johnson & Johnson is facing the first lawsuits in Britain over allegations that its talc products cause cancer, as it fights tens of thousands of similar claims in the United States.

LONDON, Oct 16 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab is facing the first lawsuits in Britain over allegations that its talc products cause cancer, as it fights tens of thousands of ...

Two years after spinning off its $15 billion consumer health unit as Kenvue, Johnson & Johnson is slimming down again by unveiling a plan to separate its orthopedics business, transforming it into a ...

Johnson & Johnson said Tuesday that it plans to spin out its orthopedics business, creating a standalone company that would compete with firms like Stryker and Zimmer Biomet. The healthcare giant said ...